4//SEC Filing
AMICUS THERAPEUTICS INC 4
Accession 0001209191-14-055071
$FOLDCIK 0001178879operating
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:51 PM ET
Size
8.5 KB
Accession
0001209191-14-055071
Insider Transaction Report
Form 4
Gershkowitz Jayne
VP, Patient Advocacy
Transactions
- Purchase
Common stock
2014-08-27$7.00/sh+5,000$35,000→ 55,000 total - Exercise/Conversion
Stock Options (right to buy)
2014-08-27−5,000→ 0 totalExercise: $3.32From: 2014-03-01Exp: 2020-03-16→ Common Stock (5,000 underlying) - Sale
Common stock
2014-08-27$7.00/sh−5,000$35,000→ 50,000 total
Footnotes (1)
- [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2014.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001178879
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:51 PM ET
- Size
- 8.5 KB